anti-obesity treatments

Boehringer Ingelheim and Gubra Join Forces to Identify and Validate Innovative Peptides for the Treatment of Obesity

Hørsholm, Denmark & Ingelheim, Germany:    The research agreement builds upon the successful relationship between Boehringer Ingelheim and Gubra and expands…

Read More »